Replies to post #201542 on Cytodyn Inc (CYDY)

[jimmy667]

Amgen bought FPRX not even in Phase 3 for $38. FPRX traded below $5 five months earlier before the bidding war started. FPRX drug of interest for the buyout was a immuno- cancer drug for Gastric Cancer.